FirmaIQ
Org.nr 994 464 663 2016 → 2017 Year-over-year analysis

HOFSETH BIOCARE ASA: årsregnskap 2017 vs 2016

Grew 379% on revenue, stronger earnings, fresh owner capital

approved 2018-03-16; registry 2018-06-23; journal 2018 530136

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2017 with 2016 for HOFSETH BIOCARE ASA. Revenue 19.75m NOK → 94.54m NOK (+378.6%). Net result -146.18m NOK → -36.17m NOK. Equity 73.85m NOK → 37.68m NOK.

On the constructive side: revenue rose; net result improved; cash rose. Pressures included: equity eroded.

Also worth watching: payroll increased; book investments changed. All figures are taken from the published annual accounts for HOFSETH BIOCARE ASA.

At a glance

Scorecard

Revenue
19.75m NOK 94.54m NOK
+378.6%
Net result
-146.18m NOK -36.17m NOK
+75.3%
Equity
73.85m NOK 37.68m NOK
-49.0%
Cash
14.12m NOK 40.98m NOK
+190.2%
Total assets
168.49m NOK 202.9k NOK
-99.9%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 19.75m NOK to 94.54m NOK (+378.6% YoY). Calculated

  • ↑

    Net result improved

    Net result -146.18m NOK → -36.17m NOK (net margin -740.1% → -38.3%). Calculated

  • ↑

    Cash rose

    Bank deposits 14.12m NOK → 40.98m NOK (+190.2% YoY). Calculated

  • ↑

    Owners injected capital

    Paid-in equity rose 233.5k NOK → 37.68m NOK (+37.44m NOK). Reported fact

What deteriorated

  • ↓

    Equity eroded

    Book equity 73.85m NOK → 37.68m NOK (equity ratio 43.8% → 18567.5%). Calculated

Things to notice

  • ·

    Payroll increased

    Salary cost 14.48m NOK → 21.02m NOK (73% → 22% of revenue). Calculated

  • ·

    Book investments changed

    Investment / intangible book value 24.62m NOK → 29.61m NOK. Reported fact